Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Intangibles: 2019-2025

Historic Intangibles for Legend Biotech (LEGN) over the last 5 years, with Jun 2025 value amounting to $2.1 million.

  • Legend Biotech's Intangibles fell 22.91% to $2.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $2.1 million, marking a year-over-year decrease of 22.91%. This contributed to the annual value of $2.2 million for FY2024, which is 46.81% down from last year.
  • Legend Biotech's Intangibles amounted to $2.1 million in Q2 2025, which was up 2.64% from $2.1 million recorded in Q1 2025.
  • Legend Biotech's Intangibles' 5-year high stood at $6.4 million during Q4 2021, with a 5-year trough of -$1.3 million in Q2 2022.
  • Moreover, its 3-year median value for Intangibles was $2.1 million (2024), whereas its average is $1.9 million.
  • In the last 5 years, Legend Biotech's Intangibles skyrocketed by 521,205.18% in 2021 and then crashed by 127.60% in 2022.
  • Legend Biotech's Intangibles (Quarterly) stood at $6.4 million in 2021, then slumped by 46.75% to $3.4 million in 2022, then increased by 19.13% to $4.1 million in 2023, then crashed by 46.81% to $2.2 million in 2024, then dropped by 22.91% to $2.1 million in 2025.
  • Its Intangibles stands at $2.1 million for Q2 2025, versus $2.1 million for Q1 2025 and $2.2 million for Q4 2024.